Latest Articles
Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer - OncLive
Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer OncLive
Published: April 24, 2024, 7 a.m.
Rucaparib Maintenance Therapy in Recurrent/Metastatic Endometrial Cancer - Oncology Learning Network
Rucaparib Maintenance Therapy in Recurrent/Metastatic Endometrial Cancer Oncology Learning Network
Published: March 21, 2024, 7 a.m.
Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer - Medpage Today
Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer Medpage Today
Published: March 19, 2024, 7 a.m.
“Unprecedented OS Benefit” Seen in Advanced, Recurrent Endometrial Cancer - Oncology News Central
“Unprecedented OS Benefit” Seen in Advanced, Recurrent Endometrial Cancer Oncology News Central
Published: March 17, 2024, 7 a.m.
RUBY Part 2 trial results: Potentially practice changing results in advanced/recurrent endometrial cancer - EurekAlert
RUBY Part 2 trial results: Potentially practice changing results in advanced/recurrent endometrial cancer EurekAlert
Published: March 16, 2024, 7 a.m.
Link copied to clipboard!